Skip to main content

Table 4 Linear Regression Model to estimate predictors of QoL (last follow-up visit)

From: Impact of Treviamet® & Treviamet XR® on quality of life besides glycemic control in type 2 DM patients

Variables

B

SE

β

t

p-value

95% CI

LB

UB

Age

0.024

0.101

0.022

0.238

0.813

-0.176

0.224

Gender

5.297

1.998

0.268

2.652

0.009*

1.333

9.260

Marital Status

-4.969

4.380

-0.103

-1.134

0.259

-13.660

3.722

Education level

-1.534

1.333

-0.110

-1.152

0.252

-4.178

1.110

Income

1.011

1.325

0.073

0.763

0.447

-1.617

3.639

Number of dependents

-0.064

0.319

-0.019

-0.201

0.841

-0.697

0.569

Smoking/Tobacco Use

-0.897

1.415

-0.058

-0.634

0.528

-3.704

1.911

Weight$

0.097

0.080

0.118

1.208

0.230

-0.062

0.256

Systolic blood pressure$

0.127

0.139

0.106

0.913

0.363

-0.149

0.402

Diastolic Blood Pressure$

-0.147

0.208

-0.084

-0.705

0.483

-0.560

0.266

Fasting Plasma Glucose$

-0.013

0.052

-0.026

-0.258

0.797

-0.117

0.090

HbA1c$

3.488

1.101

0.299

3.168

0.002*

1.304

5.673

Hypoglycemia$

-16.012

10.305

-0.151

-1.554

0.123

-36.460

4.436

Diarrhea$

22.270

9.433

0.416

2.361

0.020*

3.553

40.987

Abdominal discomfort$

-21.356

10.853

-0.347

-1.968

0.052*

-42.892

0.179

Indigestion$

-9.674

9.694

-0.092

-0.998

0.321

-28.908

9.560

  1. Unstandardized Coefficients (B); Standard Error-SE; Standardized Coefficient-Beta (β); Confidence Interval (CI); Lower Boundary (LB); Upper Boundary (UB)
  2. $At last follow-up visit
  3. R2 = 0.265, Adj R2 = 0.146, F(16, 99) = 2.231, *p < 0.05 is considered significant
  4. Nausea, Vomiting, Flatulence, and Asthenia are constants or have missing correlations; they were deleted from the analysis